RespiQ: Funding, Investors & Team (Sep 2026)
RespiQ, a start-up from the Netherlands, is working on an innovative breath analysis sensor that combines AI technology to diagnose and manage diseases in real-time. With our cost-effective and non-invasive monitoring solution, users can easily use it at healthcare facilities or in their own homes. Our ultimate goal is to further develop our groundbreaking technology to create a breath biopsy that can accurately identify a wide range of disease markers. This method has the potential to revolutionize testing for diseases such as metabolic disorders, respiratory conditions like COPD, cancer, heart disease, inflammation-related illnesses, and infectious diseases.
RespiQ has raised $4.4M across 1 funding round on record, the most recent an undisclosed round of $4.4M announced in Nov 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
RespiQ Company Profile and Key Stats
Latest funding round on record: Nov 2023.
RespiQ Funding Rounds
RespiQ Founders and Leadership Team
No contact details are on record for this team yet.
RespiQ Funding Compared to Other Biotechnology Startups
RespiQ's latest round of $4.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RespiQ in Biotechnology and Amsterdam
Companies Similar to RespiQ
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
RespiQ Funding FAQs
What does RespiQ do?
RespiQ, a start-up from the Netherlands, is working on an innovative breath analysis sensor that combines AI technology to diagnose and manage diseases in real-time. With our cost-effective and non-invasive monitoring solution, users can easily use it at healthcare facilities or in their own homes. Our ultimate goal is to further develop our groundbreaking technology to create a breath biopsy that can accurately identify a wide range of disease markers. This method has the potential to revolutionize testing for diseases such as metabolic disorders, respiratory conditions like COPD, cancer, heart disease, inflammation-related illnesses, and infectious diseases.
How much funding has RespiQ raised?
RespiQ has raised $4.4M across 1 round on record. The most recent is an undisclosed round of $4.4M announced in Nov 2023.
When did RespiQ last raise funding?
RespiQ's most recent funding round on record is an undisclosed round of $4.4M, announced in Nov 2023.
Who is the CEO of RespiQ?
Mira Gleisberg is listed as CEO at RespiQ.
Where is RespiQ headquartered?
RespiQ is based in Amsterdam, Noord-Holland, Netherlands.
How many employees does RespiQ have?
RespiQ is in the 1-10 employee band.
How does RespiQ's funding compare to other Biotechnology startups?
RespiQ's latest round of $4.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's RespiQ Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RespiQ is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.